Profitable New Cannabis Accelerator Combines Social Equity With Merit at Health Advance Inc and SoEquity
Health Advance Inc (OTC: HADV) and SoEquity have launched a cannabis accelerator program, approving their first social equity cannabis license owner, InLabs2 of Springfield, Illinois. The program aims to boost business success through targeted mentorship and funding, while sharing benefits with public investors.
The alliance's business model focuses on identifying qualified social equity license owners in states with capped licensing, providing expertise, mentorship, and financing to maximize performance. InLabs2, led by William Bishop III, has agreed to a joint venture that provides the Health Advance/SoEquity alliance with partial ownership and profit sharing.
Health Advance is supporting SoEquity 's qualification with the SEC for a $75 Million public offering under Regulation A+. The initiative represents the first time public investors have had access to social equity targeted deal flow within the cannabis sector.
Health Advance Inc (OTC: HADV) e SoEquity hanno lanciato un programma di accelerazione per la cannabis, approvando il primo proprietario di licenza di cannabis per l'equità sociale, InLabs2 di Springfield, Illinois. Il programma mira a migliorare il successo aziendale attraverso mentorship mirate e finanziamenti, condividendo i benefici con gli investitori pubblici.
Il modello di business dell'alleanza si concentra sull'identificazione di proprietari di licenze per l'equità sociale qualificati in stati con licenze limitate, fornendo esperienza, mentoring e finanziamenti per massimizzare le prestazioni. InLabs2, guidata da William Bishop III, ha concordato una joint venture che fornisce all'alleanza Health Advance/SoEquity una proprietà parziale e una condivisione dei profitti.
Health Advance sta supportando la qualificazione di SoEquity presso la SEC per un offerta pubblica di 75 milioni di dollari ai sensi della Regola A+. L'iniziativa rappresenta la prima volta che gli investitori pubblici hanno avuto accesso a flussi di affari mirati all'equità sociale nel settore della cannabis.
Health Advance Inc (OTC: HADV) y SoEquity han lanzado un programa de aceleración de cannabis, aprobando su primer propietario de licencia de cannabis de equidad social, InLabs2 de Springfield, Illinois. El programa tiene como objetivo impulsar el éxito empresarial a través de mentoría y financiación específicas, compartiendo beneficios con los inversores públicos.
El modelo de negocio de la alianza se centra en identificar propietarios de licencias de equidad social calificados en estados con licencias limitadas, proporcionando experiencia, mentoría y financiamiento para maximizar el rendimiento. InLabs2, liderado por William Bishop III, ha acordado una empresa conjunta que otorga a la alianza Health Advance/SoEquity una propiedad parcial y la compartición de beneficios.
Health Advance está apoyando la calificación de SoEquity ante la SEC para una oferta pública de 75 millones de dólares bajo la Regulación A+. La iniciativa representa la primera vez que los inversores públicos tienen acceso a flujos de oferta dirigidos a la equidad social dentro del sector del cannabis.
Health Advance Inc (OTC: HADV)와 SoEquity는 대마초 가속 프로그램을 시작했으며, 사회적 형평성을 위한 첫 번째 대마초 라이선스 소유자인 InLabs2를 일리노이주 스프링필드에서 승인했습니다. 이 프로그램은 목표 멘토링과 자금을 통한 사업 성공을 촉진하고, 공공 투자자와 이익을 공유하는 것을 목표로 합니다.
이 동맹의 사업 모델은 라이선스가 제한된 주에서 자격을 갖춘 사회적 형평성 라이선스 소유자를 식별하는 데 중점을 두고, 성과 극대화를 위한 전문 지식, 멘토링 및 자금을 제공합니다. 윌리엄 비숍 III가 이끄는 InLabs2는 Health Advance/SoEquity 동맹과 부분 소유권 및 수익 공유를 제공하는 공동 투자 계약을 체결했습니다.
Health Advance는 SEC에서 7500만 달러 규모의 공모에 대한 SoEquity의 자격을 지원하고 있습니다. 이 이니셔티브는 공공 투자자가 대마초 분야 내에서 사회적 형평성 목표 거래 흐름에 접근할 수 있는 첫 번째 경우를 나타냅니다.
Health Advance Inc (OTC: HADV) et SoEquity ont lancé un programme d'accélérateur de cannabis, en approuvant leur premier propriétaire de licence de cannabis pour l'équité sociale, InLabs2 de Springfield, Illinois. Le programme vise à stimuler le succès commercial grâce à un mentorat ciblé et à un financement, tout en partageant les bénéfices avec les investisseurs publics.
Le modèle commercial de l'alliance se concentre sur l'identification des propriétaires de licences d'équité sociale qualifiés dans des États à licence limitée, fournissant expertise, mentorat et financement pour maximiser les performances. InLabs2, dirigé par William Bishop III, a accepté un partenariat qui confère à l'alliance Health Advance/SoEquity une part de propriété partielle et un partage des bénéfices.
Health Advance soutient la qualification de SoEquity auprès de la SEC pour une offre publique de 75 millions de dollars en vertu de la Réglementation A+. Cette initiative représente la première fois que les investisseurs publics ont eu accès à des flux d'affaires ciblés sur l'équité sociale dans le secteur du cannabis.
Health Advance Inc (OTC: HADV) und SoEquity haben ein Cannabis-Beschleunigungsprogramm gestartet und den ersten Lizenzinhaber für soziale Gerechtigkeit, InLabs2 aus Springfield, Illinois, genehmigt. Das Programm zielt darauf ab, den Geschäftserfolg durch gezielte Mentorship und Finanzierung zu steigern, während die Vorteile mit öffentlichen Investoren geteilt werden.
Das Geschäftsmodell der Allianz konzentriert sich auf die Identifizierung qualifizierter Lizenzinhaber für soziale Gerechtigkeit in Staaten mit begrenzten Lizenzen und bietet Fachwissen, Mentoring und Finanzierung zur Maximierung der Leistung. InLabs2, geleitet von William Bishop III, hat eine gemeinsame Unternehmung vereinbart, die der Health Advance/SoEquity-Allianz teilweise Eigentum und Gewinnbeteiligung gewährt.
Health Advance unterstützt SoEquity bei der Qualifikation bei der SEC für ein 75 Millionen Dollar öffentliches Angebot gemäß Regulation A+. Die Initiative stellt das erste Mal dar, dass öffentliche Investoren Zugang zu auf soziale Gerechtigkeit ausgerichteten Geschäftsmöglichkeiten im Cannabissektor haben.
- Secured partial ownership and profit sharing in InLabs2 , a licensed cannabis operation
- Operating in Illinois' capped cannabis market with competition
- Pipeline of additional joint venture candidates ready for evaluation
- Strategic positioning for $75M Regulation A+ public offering
- Requires significant capital deployment for future ventures
- Success dependent on regulatory compliance in cannabis sector
- Early stage of program implementation with unproven financial results
Innovative Approach Drives Profitability of Cannabis Operations for Public Shareholders Through Social Equity License Owners
The partners are boosting the business success of social equity cannabis license owners through targeted mentorship and funding, and passing those benefits through to their public investors. SoEquity Founder and CEO, Calvin Frye, is acknowledged by regulators as an expert in this pursuit. Frye has been showcased by the Los Angeles Department of Cannabis Regulation and government legislators nationally.
VIDEO: https://www.youtube.com/watch?v=UgFJAoOn-SM
By improving the success rate of social equity cannabis license owners, the Health Advance / SoEquity accelerator program helps cannabis regulators achieve their goal of a thriving licensed community, while respecting social equity ownership objectives. This initiative is establishing a leadership role for Health Advance / SoEquity in a valuable limited access market.
InLabs2 LLC is a case in point. It was granted a Craftgrow and Infusion Cannabis License under a program promoting social equity ownership in cannabis business opportunities.
InLabs2 LLC, www.InLabs2.com, is led by
Mr. Bishop, CEO of InLabs2, comments - "Calvin is a pioneer. Thousands of people in the industry and in the community know him. That's not even an exaggeration. I am really excited to be working with Calvin and his team. It's been hard for me to secure capital and get the best advice in this space even though I have a terrific license and skills. Now, in the joint venture concept, Calvin's track record becomes our track record. We grow together as a team, sharing the rewards with our new public shareholders. We are going to show them what we can do. This is going to grow, man. This is needed. It's fantastic."
Although InLabs2 LLC is the first joint venture approved by the alliance, there are more in the pipeline. Additional applicants are eager to share what they have, for mutual gain. Applicants are proving with their high quality business plans that they have lucrative legal cannabis opportunities that are being wasted due to missing mentoring and financing.
SoEquity Corporation's Calvin Frye comments – "I'm proud of the SoEquity mission to help an unserved entrepreneurial community get a fair shot at being prosperous within the cannabis industry, while at the same time delivering exceptional financial performance. Our accelerator program combines merit and social equity for best results. It's about smart business and doing the right thing. It's good for everyone. I am being approached a lot now, since the word got out about what we are doing. It's big. I can feel it."
President of Health Advance, Larry McLachlin, concludes, "Our alliance gives Health Advance shareholders huge upside. Calvin's network is vast. What we are doing together is massively scalable. There is a lot of positive human energy around this. It has come together nicely. When SoEquity gets the Reg A+ funding, the whole thing will go to another level. We'll have tons of developments to report to our shareholders. That's important – continuous real advances to share – that's gold."
ABOUT SOEQUITY CORPORATION
SoEquity Corporation, whose credo is "Social Equity Capital Management for Profit and Progress" is in the process of formation for the purpose of qualifying for a
ABOUT HEALTH ADVANCE INC
Health Advance is a Current Information tier filer with OTC Markets in the Alternative Reporting Standards category. Health Advance Inc is organizing joint venture initiatives to realize the company's charter mission to be active in the health and wellness oriented marketplace, broadly defined.
SAFE HARBOR STATEMENT
Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.
MEDIA / INTERVIEWS
Calvin Frye, Founder & CEO
SoEquity Corporation
(818) 744-4617
www.SoEquityCorporation.com
www.RealCalvinFrye.com
Info@soequitycorporation.com
Larry McLachlin, President
Health Advance, Inc
(705) 733-7098
9131 Keele Street, Suite A4
President@HealthAdvanceGroup.com
www.Twitter.com/HADVPresident
Photo - https://mma.prnewswire.com/media/2608425/Calvin_frye.jpg
Logo - https://mma.prnewswire.com/media/2608426/InLabs_2.jpg
Logo - https://mma.prnewswire.com/media/2608427/SoEquity_Corporation.jpg
Logo - https://mma.prnewswire.com/media/2608424/Health_Advance_Inc_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/profitable-new-cannabis-accelerator-combines-social-equity-with-merit-at-health-advance-inc-and-soequity-302363136.html
SOURCE Health Advance, Inc
FAQ
What is the first cannabis company approved for Health Advance's (HADV) accelerator program?
How will HADV benefit from the partnership with InLabs2 ?
What is the size of SoEquity's planned Regulation A+ offering supported by HADV?
How does HADV's cannabis accelerator program generate value for shareholders?